These findings implicate that Oct3−/− mice are more susceptible for liver tumor development due to enhanced proliferation and match the results in human HCC that the downregulation of OCT expression is associated with advanced tumor stages [15]. The gene discussed is PLXNA2; the disease is hepatocellular carcinoma.